(Q46929763)

26 December 2017

http://europepmc.org/abstract/MED/24553436

title

Angiotensin 1-7 mediates renoprotection against diabetic nephropathy by reducing oxidative stress, inflammation, and lipotoxicity (English)

1 reference

26 December 2017

http://europepmc.org/abstract/MED/24553436

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24553436%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Tharmarajan Ramprasath

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24553436%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

Jun Mori

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24553436%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Osama Abo Alrob

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24553436%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Jessica DesAulniers

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24553436%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

James W Scholey

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24553436%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Gary D Lopaschuk

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24553436%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Gavin Y Oudit

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24553436%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

publication date

19 February 2014

1 reference

26 December 2017

http://europepmc.org/abstract/MED/24553436

published in

American Journal of Physiology - Renal Physiology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24553436%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

volume

306

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24553436%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24553436%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

page(s)

F812-21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24553436%20AND%20SRC:MED&resulttype=core&format=json

Obesity-initiated metabolic syndrome and the kidney: a recipe for chronic kidney disease?

6 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

Loss of TIMP3 selectively exacerbates diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

Enhanced expression of Janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

Mouse models of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

Epigenetic regulation of angiotensin-converting enzyme 2 (ACE2) by SIRT1 under conditions of cell energy stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

Pathogenesis, prevention, and treatment of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

Prevalence of chronic kidney disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

Effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

Modulation of the action of insulin by angiotensin-(1-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

Type 2 diabetes as an inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

Loss of ACE2 exacerbates murine renal ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

Angiotensin-(1-7) activates a tyrosine phosphatase and inhibits glucose-induced signalling in proximal tubular cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

Oxidative stress and diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

Identification of prolyl carboxypeptidase as an alternative enzyme for processing of renal angiotensin II using mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

Diabetic nephropathy: mechanisms of renal disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

Protective role of JAK/STAT signaling against renal fibrosis in mice with unilateral ureteral obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

Angiotensin-(1-7)-induced activation of ERK1/2 is cAMP/protein kinase A-dependent in glomerular mesangial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

Oxidative stress and glutathione in TGF-beta-mediated fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

Agonist-induced hypertrophy and diastolic dysfunction are associated with selective reduction in glucose oxidation: a metabolic contribution to heart failure with normal ejection fraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

Lipotoxicity in diabetic nephropathy: the potential role of fatty acid oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

Human recombinant ACE2 reduces the progression of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

Loss of angiotensin-converting enzyme-2 exacerbates diabetic cardiovascular complications and leads to systolic and vascular dysfunction: a critical role of the angiotensin II/AT1 receptor axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

Genetic deletion of the angiotensin-(1-7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

An update on the lipid nephrotoxicity hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

The RAAS in the pathogenesis and treatment of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

High-fat diet induces an initial adaptation of mitochondrial bioenergetics in the kidney despite evident oxidative stress and mitochondrial ROS production

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

Recent insights into diabetic renal injury from the db/db mouse model of type 2 diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

Obesity is associated with macrophage accumulation in adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

Regulation of urinary ACE2 in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

Obesity-metabolic derangement preserves hemodynamics but promotes intrarenal adiposity and macrophage infiltration in swine renovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

Global and societal implications of the diabetes epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00655.2013

10.1152/AJPRENAL.00655.2013

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24553436%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

1 reference